Roujiren

Guangzhou Roujiren Technology Co., Ltd. develops intelligent nursing care robots designed to assist bedridden elderly individuals with daily activities. The company emerged in 2018 through the transformation of Boshi Research Institute, bringing decades of medical device expertise into the emerging smart elderly care sector.

Company Overview

Roujiren positions itself at the intersection of robotics and geriatric care, addressing one of China’s most pressing demographic challenges. With over 46 million disabled elderly individuals in China—approximately 20 million of whom are moderately to severely bedridden—the shortage of professional caregivers exceeds 10 million by international staffing standards.

The company has secured over RMB 10 million in funding through China’s National Key R&D Program, validating its technical approach to solving the caregiver shortage through automation. Roujiren has established strategic partnerships with leading academic institutions including Shanghai University of Science and Technology’s Intelligent Rehabilitation Engineering Research Institute, Beihang University’s Robotics Research Institute, Shanghai Jiao Tong University, Fudan University, and Hebei University of Technology.

Core Products

Elderly Care Nursing Robot System (Bed-Chair-Bath Transfer System)

The flagship product integrates multiple transfer functions into a unified system capable of assisting bedridden patients with bed-to-wheelchair transitions, indoor mobility, toileting, and bathing—all traditionally requiring multiple caregivers. The system features a specialized wheelchair that can rotate in place, move horizontally and vertically, and transition between seated and reclined positions for smooth docking with beds, toilets, and bathing facilities.

Additional Product Lines

The company has developed over 20 medical and rehabilitation products protected by more than 100 domestic and international patents. These include:

• Ophthalmic examination robot
• Intelligent negative-pressure dry eye treatment device
• Intelligent prism examination instrument
• Suspended rail nursing robot
• Limb rehabilitation robots (in development)

Technology & Innovation

Roujiren’s technical approach centers on creating integrated systems rather than standalone devices. The bed-chair-bath transfer system represents what the company describes as a full solution that can replace multiple traditional caregiving tasks. Key innovations include:

• Automatic rotation and multi-directional movement capability
• Smooth transition between sitting and lying positions
• Direct docking interfaces for beds, toilets, and bathing facilities
• Single-caregiver operation for tasks traditionally requiring two or more staff

The company holds patents establishing what it claims as a 10-year technical barrier in the nursing care robot segment.

Market Presence

Roujiren targets three primary channels aligned with China’s tiered elderly care infrastructure:

1. Government procurement: Leveraging its National Key R&D Program status for inclusion in public procurement lists
2. Smart Healthy Elderly Care demonstration zones: Targeting thousands of government-designated pilot communities, districts, and facilities
3. Institutional sales: Direct sales to nursing homes, community care centers, and healthcare facilities

The company plans to establish automated production facilities capable of 30 units per day, with subsequent expansion to 5-10 factories nationwide supporting daily output exceeding 300 units. Target pricing is approximately RMB 100,000 per system.

Development Status

As of late 2024, Roujiren was in the pre-production mold adjustment phase, preparing for initial batch manufacturing of 200 units. The company has been demonstrating its technology at industry exhibitions, including the Global Rehabilitation Technology Congress in collaboration with Shanghai University of Science and Technology.

The company has announced plans for Pre-A round financing seeking RMB 50 million for 10% equity at a RMB 500 million valuation, with funds designated for production scaling, talent recruitment, and market development.

Key Milestones

• 2018: Company established through transformation of Boshi Research Institute
• 2020s: Secured National Key R&D Program funding exceeding RMB 10 million
• 2024: Completed prototype development; entered pre-production phase
• 2024: Joint exhibition with Shanghai University of Science and Technology at Global Rehabilitation Technology Congress

Frequently Asked Questions

What problem does Roujiren’s nursing robot solve?

The system addresses the severe caregiver shortage in China’s elderly care sector by enabling a single operator to perform transfer and daily care tasks that traditionally require two or more caregivers, including moving bedridden patients between bed, wheelchair, toilet, and bathing facilities.

Has Roujiren received regulatory approval for its products?

The company has not publicly announced NMPA medical device registration for its nursing robot system. Products are currently in the pre-production development phase.

What is Roujiren’s relationship with universities?

Roujiren maintains strategic R&D partnerships with multiple leading Chinese universities, with Shanghai University of Science and Technology’s Intelligent Rehabilitation Engineering Research Institute serving as a primary joint development partner for the flagship nursing robot system.